- Home
- TPST vs PIII Comparison
TPST vs PIII Comparison
Compare TPST & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPST | PIII |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 13.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TPST | PIII |
|---|---|---|
| Price | $2.95 | $3.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $12.50 | ★ $16.25 |
| AVG Volume (30 Days) | ★ 119.2K | 11.3K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,444,952,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.87 | $3.50 |
| 52 Week High | $13.65 | $14.50 |
Technical Indicators
Market Signals| Indicator | TPST | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 27.63 | 20.83 |
| Support Level | $2.87 | $3.51 |
| Resistance Level | $3.20 | $3.85 |
| Average True Range (ATR) | 0.13 | 0.25 |
| MACD | 0.24 | -0.04 |
| Stochastic Oscillator | 27.78 | 5.18 |
Price Performance
Historical ComparisonAbout TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.